November 2022 - Page 2 of 9

TuesdayNov 29, 2022 9:45 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Positioned to Fill Data Void as Governments and Tech Companies Phase Out Third-Party Cookies

Governments are taking action to regulate, limit, or eliminate the use of third-party cookies that collect user information The European Union ePrivacy Directive requires parties to obtain user consent before sending cookies Google intends to phase out support for third-party cookies from its Chrome browser in 2024 Reklaim’s fully consensual, consumer-verified data ecosystem offers a high-quality, fully compliant solution to advertisers and data companies while rewarding users for providing access to data The online advertising industry is transforming rapidly as governments take action to regulate, limit, or eliminate the use of third-party cookies. As a result, Reklaim (TSX.V: MYID) (OTCQB:…

TuesdayNov 29, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Investigation of DehydraTECH-CBD’s Potential Therapeutic Value for Diabetes and Defmentia with New Studies

Lexaria’s Patented DehydraTECH technology improves the bioavailability of pharmaceuticals and therapeutics for a number of developing applications Lexaria is set to complete its DEM-A22-1 and DIAB-A22-1 studies on dementia and diabetes, respectively, in January 2023, with analysis and reporting set to follow soon after These studies will build on the just-concluded hypertension clinical study whose results were “truly exceptional,” demonstrating a statistically significant lowering of blood pressure in the patient population over multiple weeks There is an established link between hypertension and vascular dementia, along with hypertension being twice as frequent in people with diabetes and hypertensive patients being at…

MondayNov 28, 2022 2:15 pm

IRA Catalyzes Solar Stocks as GeoSolar Technologies Inc. Eyes Public Listing

The Inflation Reduction Act (“IRA”), a linchpin to the U.S. meeting its emissions goals, includes $369 billion dedicated to expanding renewable energy The new bill is projected to generate $600 billion in capital investment, 550,000 clean energy jobs, and 525-550 gigawatts of new clean power The passage of the IRA served as a catalyst to solar stocks and continues to grow interest in upstarts like GeoSolar Technologies President Joe Biden is on a mission to cement his legacy as an ambassador of all things anti-climate change. The passage of the Inflation Reduction Act will forever be his key piece of…

MondayNov 28, 2022 1:30 pm

Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Achieve ESG Goals Through Proprietary Analytics, Advisement

Corporations worldwide are working to improve their climate friendliness through a variety of environmental, social and governance (“ESG”) factors U.S. distributed energy solutions innovator Correlate Infrastructure Partners Inc. is a company working strategically with clients to assess their energy emissions profile and identify possible improvements and funding opportunities for those improvements CIPI’s advisement helps clients achieve transparency in their ESG responsibility and to make improvements in a cost-beneficial manner CIPI has realized record revenues during the most recent quarter as a result of its operations and still has $16.2 million in unrecognized revenues anticipated from work currently under way Environmental,…

MondayNov 28, 2022 12:45 pm

RHK 2022 Disruptive Growth Conference to Introduce Disruptive Growth Companies to New Investors

RHK Capital is organizing the RHK Capital 2022 Disruptive Growth Conference, at the offices of Reed Smith, NYC. Spread over two days on December 5-6, 2022, investors, brokers, wealth managers, capitalists, growth companies and enterprises, are invited to attend this interactive learning and network-building conference in person or via webcast. The focus of RHK Capital in this in person and webcast conference is to spotlight aspiring companies and young industries with disruptive growth potential. The RHK Capital 2022 Disruptive Growth Conference is attended by over 200 institutional investors, accredited investors, family offices, Wall Street analysts, financial advisors, broker-dealer wealth managers,…

MondayNov 28, 2022 12:00 pm

Lift Events & Experiences to Bring Unique Cannabis Conference, Trade Show and Associated Opportunities to the U.S. Cannabis Market

Become a part of the 2023 U.S. debut of Lift Events & Experiences, at the Moscone Center in San Francisco, from Wednesday, August 2 – Friday, August 4, 2023. The leader in Canada, Lift’s first conference over the border offers exclusive content, robust networking, and unparalleled new product discovery opportunities. The event is dedicated to the evolution of the cannabis industry, and brings to the U.S. Lift’s long-established and respected reputation for powerful cannabis events. After proving its mettle in Vancouver and Toronto, the former Lift&Co. Expo will now simply be called ‘Lift’, reflecting its expanding footprint. Lift invites attendees…

MondayNov 28, 2022 11:15 am

CubCrafters Inc. Sees Increased Investor Interest as it receives Reg A Qualification by the SEC; Company Production Currently Sold Out Through Late-2024

CubCrafters’ announcement about filing for Reg A qualification with the SEC was met with enthusiasm as investors pledged $5 million in reservations for 1 million planned shared in the first 48 hours following the announcement The company intends to use some of the infusion of funding to accelerate production rates as they are sold out through late-2024and anticipate taking orders for 2025 soon The backcountry aircraft market is expected to reach $11.9 billion by 2030 CubCrafters company focuses on four main product lines – the Carbon Cub FX, NXCub, XCub, and Carbon Cub EX kits, and announced a new engine…

MondayNov 28, 2022 10:30 am

REZYFi, Inc. Leverages Growth of California’s Cannabis Market as It Expands to Include Social Equity Provisions, More Opportunities for Business Owners

California retail stores sold almost $5.3 billion worth of cannabis products in 2021 and reported a total tax revenue of approximately $1.3 billion California’s three licensing authorities issued 12,227 commercial cannabis licenses to businesses throughout the state during 2021 San Diego has approved a social-equity program, joining the ranks of other California cities and counties that have implemented them since 2018, utilizing tax revenues from the cannabis industry REZYFi is the first cannabis mortgage company in the United States – a market where most traditional lenders are still reticent to enter On November 8, 2016, California voters approved cannabis for…

MondayNov 28, 2022 9:45 am

SideChannel Inc. (SDCH) Simplifies Cybersecurity by Matching SMBs with Virtual Chief Information Security Officers to Reduce Internal Costs

Cyberattacks on SMBs have increased due to the changing network landscape due to the increase in remote and in-office workers relying on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business SideChannel announced its preliminary revenue of $4.6 to $4.8 million for the fiscal year that ended September 30, 2022 – a 64% to 71% year-over-year increase from the company's revenue of $2.8 million during the fiscal year 2021 SideChannel continues to expand its service offerings, workforce, and customer base and has attracted over 20 vCISOs to serve across industries, including fintech, biotech, healthcare, manufacturing, legal defense,…

MondayNov 28, 2022 9:00 am

European Clinical Trial Site Expansion for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Brain Cancer Drug Candidate Drives Patient Enrollment

U.S.-based drug innovator CNS Pharmaceuticals is continuing to advance its global human clinical trial for Berubicin, a potentially pivotal treatment for the incurable brain cancer glioblastoma CNS recently announced its Q3 financial results, including an update on the clinical development that noted the start of patient enrollment and dosing in France CNS is also advancing trial sites in the United States, Switzerland, Spain, and Italy, with 29 of 68 anticipated sites currently enrolling patients The company expects to provide an interim analysis of the trials in mid-2023 and primary completion in 2024, with ultimate resolution in 2025 The FDA has…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: November 2022